Gene · 4647
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selection of viral capsids and promoters affects the efficacy of rescue of Tmprss3-deficient cochlea. | Mol Ther Methods Clin Dev | 2023 | 37663645 | PubTator, text mining | PubMed |
| A knowledge graph approach to predict and interpret disease-causing gene interactions. | BMC Bioinformatics | 2023 | 37644440 | PubTator, text mining | PubMed |
| A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling. | Cells | 2023 | 37626864 | PubTator, text mining | PubMed |
| Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing. | Nat Commun | 2023 | 37626063 | PubTator, text mining | PubMed |
| Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer. | Open Life Sci | 2023 | 37588994 | PubTator, text mining | PubMed |
| Expression of two major isoforms of MYO7A in the retina: Considerations for gene therapy of Usher syndrome type 1B. | Vision Res | 2023 | 37586294 | PubTator, text mining | PubMed |
| Exome sequencing identifies novel variants associated with non-syndromic hearing loss in the Iranian population. | PLoS One | 2023 | 37561809 | PubTator, text mining | PubMed |
| Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review. | Invest Ophthalmol Vis Sci | 2023 | 37466950 | PubTator, text mining | PubMed |
| Myosin XV is a negative regulator of signaling filopodia during long-range lateral inhibition. | bioRxiv | 2023 | 37461640 | PubTator, text mining | PubMed |
| Clinical Characteristics and Genetic Variants of a Large Cohort of Patients with Retinitis Pigmentosa Using Multimodal Imaging and Next Generation Sequencing. | Int J Mol Sci | 2023 | 37446072 | PubTator, text mining | PubMed |
| Optimization of Capillary-Based Western Blotting for MYO7A. | Adv Exp Med Biol | 2023 | 37440024 | PubTator, text mining | PubMed |
| Variability in Cochlear Implantation Outcomes in a Large German Cohort With a Genetic Etiology of Hearing Loss. | Ear Hear | 2023 | 37438890 | PubTator, text mining | PubMed |
| Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations. | PLoS One | 2023 | 37432935 | PubTator, text mining | PubMed |
| Usher syndrome proteins ADGRV1 (USH2C) and CIB2 (USH1J) interact and share a common interactome containing TRiC/CCT-BBS chaperonins. | Front Cell Dev Biol | 2023 | 37427378 | PubTator, text mining | PubMed |
| Defining developmental trajectories of prosensory cells in human inner ear organoids at single-cell resolution. | Development | 2023 | 37381908 | PubTator, text mining | PubMed |
| Autosomal Dominant Non-Syndromic Hearing Loss (DFNA): A Comprehensive Narrative Review. | Biomedicines | 2023 | 37371710 | PubTator, text mining | PubMed |
| Impaired AIF-CHCHD4 interaction and mitochondrial calcium overload contribute to auditory neuropathy spectrum disorder in patient-iPSC-derived neurons with AIFM1 variant. | Cell Death Dis | 2023 | 37365177 | PubTator, text mining | PubMed |
| Causal factors in primary open angle glaucoma: a phenome-wide Mendelian randomisation study. | Sci Rep | 2023 | 37340071 | PubTator, text mining | PubMed |
| Single-cell transcriptomic profiling of the mouse cochlea: An atlas for targeted therapies. | Proc Natl Acad Sci U S A | 2023 | 37339214 | PubTator, text mining | PubMed |
| The actin cytoskeleton in hair bundle development and hearing loss. | Hear Res | 2023 | 37300948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4647/papers?page=9